SMS-ONCOLOGY

Business focus: SMS-ONCOLOGY is an oncology service provider with the following focus: consultancy for clinical oncology trial planning execution of early clinical development projects for pharma and biotech companies in Europe. SMS-ONCOLOGY has experience in all tumor types like Breast cancer, Leukemia, Lung cancer, Lymphomas, Prostate cancer, Colorectal and Pediatric oncology.

SMS-ONCOLOGY
Science Park 406
1098 XH Amsterdam
Website SMS-ONCOLOGY
E-mail SMS-ONCOLOGY
T +31 (0)20 435 05 80
F +31 (0)20 435 05 89

Employees in Amsterdam: 12
Employees in Hungary: 8
Employees in R&D: 10
Year of foundation: 2007

Company Profile

SMS-Oncology is a company that services oncology research and that supports market introduction of oncology compounds. SMS-oncology provides consultancy, project management and implementation of clinical study services to the Pharmaceutical and Biotech industry as well as to individual investigators and research groups.

Science and Technologies or Services

SMS-ONCOLOGY is different from other CROs due to its strong commitment to oncologists and oncology collaborative networks

Alliances

SMS-ONCOLOGY has alliances with oncologists in major academic and some peripheral in four major academic hospitals in The Netherlands and Europe.
SMS-oncology has an alliance with Indian oncology specialized hospitals for fast patient recruitment for large phase IIb and III studies.

Keywords

Oncology;
Clinical research;
Clinical development;
Breast cancer;
Leukemia;
Lung cancer;
Lymphomas;
Prostate cancer;
Colorectal;
Pediatric oncology;
Investigator;
Protocol biotech pharma.

Document Actions

Send this

Penny-wise!

Synaps bij column Arjen Brussaard, foto CNCR.nl

By Arjen Brussaard

Recently the topsector plan Life Sciences & Health was published and presented to Minister Verhagen, of the so-called ELI Ministry. The document is an amazing compressed 60-pager, based on months of hard work by the group of experts chaired by Roel Fonville, and summarizes the conclusions after dozens of 1-to-1 meetings, five regional group sessions with dozens of opinion leaders and after having received over 170 (!) memo's, white papers and letters of intent.
More...

Personal tools